Company performance
Add to research
Current Price
as of Apr 21, 2025$4.89
P/E Ratio
N/A
Market Cap
$189.68M
Description
Add to research
Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.
Metrics
Add to research
Overview
- HQBillerica, MA
- SectorHealth Technology
- IndustryMedical Specialties
- TickerQTRX
- Price$4.89-5.05%
Trading Information
- Market cap$189.68M
- Float85.51%
- Average Daily Volume (1m)755,492
- Average Daily Volume (3m)759,515
- EPS-$1.00
Company
- Revenue$137.42M
- Rev growth (1yr)12.30%
- Net income-$38.53M
- Gross margin60.47%
- EBITDA margin-32.21%
- EBITDA-$44.26M
- EV$156.09M
- EV/Revenue1.14
- P/EN/A
- P/S1.37
- P/B0.57
- Debt/Equity11.32
Documents
Add to research
SEC Filings
Earnings Calls
Factset Street Account